Summary
In recent years the role of the peripheral nervous system has been focused on the pathogenesis of rheumatoid arthritis (RA). In particular, substance P (SP), released by the sensory terminals, has been demonstrated to be involved in cartilage breakdown [13]. The aim of our work was to study the levels of SP and its peptidases, neutral endopeptidase (3.4.24.11) (NEP) and angiotensin-converting enzyme (ACE), in the synovial fluid and plasma of 30 patients with RA and 14 patients with osteoarthritis (OA). ACE and NEP were determined with a fluorimetric assay and SP with a radioimmunoassay (RIA) method. ACE levels were normal in the plasma of patients with RA and OA (6.1±1.9 and 6.7±1.4 pmol/ml/min, respectively); we found no differences in the values, of ACE between RA and OA synovial fluid (5.7±4.2 and 5.5±4.1 pmol/ml/min, respectively). NEP levels were significantly increased in plasma (139.3±36 pmol/ml/min) and synovial fluid (133.8±32 pmol/ml/min in synovial fluid) and healthy controls (89.7±14 pmol/ml/min in plasma). In synovial fluid, SP was significantly higher in RA patients (43.1±16.6 pg/ ml) than in OA patients (12±13.1 pg/ml), while plasma levels did not show any difference (RA: 14.4±10.2; OA: 13.6±10.6; healthy subjects: 11.3±3.9 pg/ml). The only relationship detected in controls and in OA was among plasma NEP and ESR (P<0.05) and synovial fluid NEP (P<0.001). Our data confirmed that SP could have a role in the pathogenesis of RA synovial inflammation through a control on neurogenic inflammation (SP degradation), vascular tone control (endothelin degradation) and on nociception (enkephalin degradation).
Similar content being viewed by others
References
Erdos EG, Skidgel RA (1987) The angiotensin I converting enzyme. Lab Invest 56:345–348
Gafford JT, Skidgel RA, Erdos EG, Hersh LB (1983) Human kidney enkephalinase, a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 22:3265–3271
Noveral JP, Mueller SN, Levine EM (1987) Release of angiotensin I converting enzyme by endothelial cells in vitro. J Cell Physiol 131:1–5
Yang H, Erdos EG, Levin Y (1970) A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 214:374–376
Skidgel RA, Engelbrecht S, Johnson A, Erdos EG (1984) Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 5:769–776
Erdos EG, Skidgel RA (1988) Human neutral endopeptidase 24.11 (enkephalinase): function, distribution and release. Adv Exp Med Biol 240:13–21
Matsas R, Kenny A, Turner AS (1984) The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogies by endopeptidase 24.11. Biochem J 223:433–440
Visayaraghavan J, Scicli AG, Carrettero OA, Slaughter C, Moomaw C, Hersh LB (1990) The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase). JBC 65:14150–14155
Levine JD, Collier DH, Basbaum AI, Moskowitz MA, Helms CA (1985) Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J Rheumatol 12:406–411
Lotz M, Carson DA, Vaughan JH (1987) Substance P activation of rheumatoid synoviocytes: neutral pathway in pathogenesis of arthritis. Science 235:893–895
Matucci-Cerinic M, Partsch G (1992) The contribution of the peripheral nervous system and the neuropeptide network to the development of synovial inflammation. Clin Exp Rheumatol. 10:211–215
Pernow B (1985) Role of tachykinins in neurogenic inflammation. J Immunol 135:8125–8155
Levine JD, Clark R, Helms C, Moskowitz MA, Basbaum AI (1984) Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226:547–552
Spillantini MG, Geppetti PA, Fanciullacci M, Michelacci S, Lecomte JM, Sicuteri F (1986) In vivo enkephalinase inhibition by acetorphan in human plasma and CSF. Eur J Pharmacol 125:147–150
Roques BP, Fournie-Zaluski MC, Soroca A, et al. (1980) The enkephalinase inhibitor, thiorphan, shares antinociceptive activity in mice. Nature 288:286–288
Spillantini MG, Sicuteri F, Salmon S, Malfroy B (1990) Characterization of endopeptidase 3.4.24.11 (enkephalinase) activity in human plasma and cerebrospinal fluid. Biochem Pharmacol 39:1353–1356
Yang HYT, Neff NH (1972) Distribution and properties of angiotensin converting enzyme of rat brain. J Neurochem 19:2443–2450
Matucci-Cerinic M, Pignone A, Lotti T, et al. (1990) Reduced angiotensin converting enzyme plasmatic activity in scleroderma. A marker of endothelial injury? J Rheumatol 17:328–330
Matucci-Cerinic M, Partsch G, Marabini S, Cagnoni M (1991) High levels of substance P in rheumatoid arthritis synovial fluid and evidence that synoviocytes are not the major source of substance P. Clin Exp Rheumatol 9:440–441
Devillier P, Weill B, Renoux M, Menkès CJ, Pradelles P (1987) Elevated levels of tachykinin-like immunoreactivity in joint fluids from patients with rheumatic inflammatory disease. N Engl J Med 314:1323
Agro A, Stanisz AM (1992) Are lymphocytes a target for substance P modulation in arthritis? Semin Arthritis Rheum 21:252–258
Menkès CJ, Renoux M, Laoussadi S, Mauborgne A, Bruxelle J, Cesselin F (1992) Substance P levels in the synovium and synovial fluid from rheumatoid arthritis and osteoarthritis. J Rheumatol (in press)
Marshall KW, Chiu B, Inman R (1990) Substance P and arthritis: analysis of plasma and synovial fluid levels. Arthritis Rheum 33:87–90
Larsson J, Ekblom A, Henriksson K, Lundeberg T, Theodorrsson E (1991) Concentration of substance P, neurokinin A, calcitonin gene related peptide, neuropeptide Y, vasointestinal peptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand J Rheumatol 20:326–335
Lowe JR, Dixon JS, Guthrie JA, McWhinney P (1986) Serum and synovial fluid levels of angiotensin converting enzyme in polyarthritis. Ann Rheum Dis 45:921–924
Blann AD (1991) Von Willebrand factor antigen and angiotensin converting enzyme in synovial fluid. Scand J Rheumatol 20:213–214
Veale D, Fitzgerald O (1990) Serum and synovial fluid angiotensin converting enzyme in inflammatory joint disease. Br J Rheumatol 29:[Suppl] 1:23
Appelboom T, de Martelaer V, de Prez E, Hauzeur JP, Deschodt-Lanckman M (1991) Enkephalinase: a physiologic neuroimmunomodulator detected in the synovial fluid. Arthritis Rheum 34:1048–1055
Hughes J, Smith JW, Hosterlitz HW, Fathergill LA, Morgan BA, Morris HR (1975) Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258:577–579
Fredrickson RCA (1977) Cyclic AMP receptor in mitochondria. Life Sci 21:23–41
Way EL, Glasgow CE (1978) The endorphins: possible physiologic roles and therapeutic applications. Clin Ther 1:371–386
Sagen J, Wang H (1990) Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplants. Eur J Pharmacol 179:427–433
Bjurholm A, Kreicbergs A, Brodin E, Schutzberg M (1988) Substance P and CGRP-immunoreactive nerves in bone. Peptides 9:165–171
Blalock JE (1989) A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol Rev 69:1–32
Partsch G, Matucci-Cerinic M (1990) Evidence that substance P is not released by capsaicin from osteoarthritis and rheumatoid arthritis synoviocytes in vitro. Ann Rheum Dis 49:653
Mapp PL, Walsh DA, Cruwys SC, Kidd BL, Blake DR (1991) Localization of neutral endopeptidase to the human synovium. Br J Rheumatol 30:121 [Suppl 2]
Sreedharan SP, Goetzl ES, Malfroy B (1990) Elevated synovial tissue concentration of the common acute lymphoblastic leukemia antigen (CALLA)-associated neutral endopeptidase (3.4.24.11) in human chronic arthritis. Immunology 71:142–144
Bathon JM, Proud D, Mizutani S, Ward PE (1992) Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides. J Clin Invest 90:981–991
Kenny HJ, Bowes MA, Gee NS, Matsas R (1985) Endopeptidase-24.11: a cell surface enzyme for metabolizing regulatory peptides. Biochem Soc Trans 13:293–295
Iwamoto I, Kimura A, Ochiai K, Tomioka H, Yoshida S (1991) Distribution of neutral endopeptidase activity in human blood leucocytes. J Leukocyte Biol 49:116–125
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matucci-Cerinic, M., Lombardi, A., Leoncini, G. et al. Neutral endopeptidase (3.4.24.11) in plasma and synovial fluid of patients with rheumatoid arthritis. A marker of disease activity or a regulator of pain and inflammation?. Rheumatol Int 13, 1–4 (1993). https://doi.org/10.1007/BF00290326
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00290326